Sign Up Today and Learn More About HelloBetter Stock

Invest in or calculate the value of your shares in HelloBetter or other pre-IPO companies through EquityZen's platform.

HelloBetter Stock (HEBE)

Leading provider of digital therapeutics for mental health: 10 DTx, 6 PDTx with universal reimbursement for 73m+ people, 33 clinical studies

Invest Now Sell Shares

About HelloBetter Stock

Founded

2015

Industries

Software, Artificial Intelligence, Financial Services

HelloBetter is a global pioneer in the field of digital therapeutics (DTx) and prescription digital therapeutics (PDTx) for mental health. Our mission is to empower people to manage and improve their mental health in a self-determined way, by allowing them to do so anywhere and at any time. The company was founded as a university-spin off in 2015 by internationally renowned research psychologists. Within the German DiGA framework, as a pioneering approach globally, HelloBetter got six online therapy programmes approved as a DiGA by the German Federal Institute for Drugs and Medical Devices (BfArM), making the digital therapeutics available on prescription and free of charge for more than 73 million people in Germany. DiGA are Prescription Digital Therapeutics that are also universally reimbursed nationwide in Germany. The six DiGA are another milestone on the company's path to making evidence-based digital mental health care accessible worldwide. Overall, HelloBetter offers 10 DTx which were evaluated in 33 randomized controlled trials (stress & burnout, diabetes & depression, chronic pain, vaginismus, panic & anxiety, insomnia, alcohol consumption, depression, stress management, depression prevention). No other provider worldwide has conducted as many clinical studies on the effectiveness of its online mental health programmes. With our €17m Series A, we push for expansion beyond the DACH region.

Stay in the know about the latest news on HelloBetter

Digital mental health startup HelloBetter secures €6M and eyes French market entry

tech • Mar 06, 2025

In other news this week: Emerge secures €68M, Faber launches third fund at €60M, Entrepreneur Peter Goedvolk turns Professor, and more

siliconcanals • Nov 09, 2024

German HelloBetter secures €3M to personalise online therapy

tech • Nov 08, 2024

Digital therapeutics finding use in Germany

mobihealthnews • Aug 04, 2024

How digital therapeutics can increase mental care access

healthcareitnews • Aug 04, 2024

Leadership team at HelloBetter

Founder, Managing Director, & CSO

Prof. Dr. David Daniel Ebert

Co-founder and VP Content & Research

Elena Heber

Join now and verify your accreditation status to gain access to:

HelloBetter Current Valuation
HelloBetter Stock Price
HelloBetter Management
Available deals in HelloBetter and all other companies with relevant Deal Offering documents
EquityZen's proprietary data and insights, which may include

HelloBetter Cap Table and Funding History by Share Class and Liquidity Preferences
HelloBetter Revenue and Financials
HelloBetter Highlights
HelloBetter Business Model
HelloBetter Risk Factors

HelloBetter Research Report from SACRA Research

Join Now

Trading HelloBetter Stock

How to invest in HelloBetter stock?

Accredited investors can buy pre-IPO stock in companies like HelloBetter through EquityZen funds. These investments are made available by existing HelloBetter shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell HelloBetter stock?

Shareholders can sell their HelloBetter stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like HelloBetter

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the U.S. Securities and Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen Inc. was awarded a 2024 Fintech Breakthrough Award by Tech Breakthrough LLC on March 19, 2025, based on the prior year and covering calendar year 2024, and has compensated FinTech Breakthrough LLC for use of its name and logo in connection with the award. FinTech Breakthrough LLC is a third party and has no affiliation with EquityZen.

EquityZen created the ticker symbols referenced on this page for use solely on the EquityZen platform. They do not refer to any publicly traded stock. EquityZen does not have an affiliation with, formal relationship with, or endorsement from any of the companies featured and none of the statements on the site should be attributed to those companies.

“Market Activity” and other transactional data displayed on this website is compiled by EquityZen and is confidential and historical in nature. Unauthorized use, distribution or reproduction is prohibited. Transactional information does not guarantee future investment results. EquityZen cannot guarantee finding or approving a transaction at any displayed price.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2025 EquityZen Inc. All rights reserved.